您的位置：首页 > 产品中心 > Bradyzide di(trifluoroacetate) salt hydrate
Bradyzide di(trifluoroacetate) salt hydrate
产品别名
Bradyzide di(trifluoroacetate) salt hydrate
(S)-1-[4-(4-Benzhydrylthiosemicarbazido)-3-nitrobenzenesulfonyl]-pyrrolidine-2-carboxylic acid [2-[(2-dimethylaminoethyl)methylamino]ethyl] amide
基本信息
| Empirical Formula【经验(实验)分子式】 | C32H42N8O5S2 · 2C2HF3O2 · xH2O |
| Molecular weight | 910.90 (anhydrous basis) |
| MDL number | MFCD02684401 |
| NACRES | NA.32 |
| Biochem/physiol Actions【生化/生理作用】 | Potent, orally active, non-peptide B2 bradykinin receptor antagonist. |
| Features and Benefits【特点和优势】 | This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. |
产品性质
| Quality Level【质量水平】 | 100 |
| Assay【测定】 | ≥98% |
| solubility【溶解性】 | H2O: >40 mg/mL |
| storage temp.【储存温度】 | −20℃ |
| packaging【包装】 | 5 mg in glass bottle 25 mg in poly bottle |
安全信息
| Storage Class Code【储存分类代码】 | 13 - Non Combustible Solids |
| WGK | WGK 3 |
| Personal Protective Equipment【个人防护装备】 | Eyeshields, Gloves, type N95 (US) |
